文献速递妇科

1990-2019年全球子宫内膜癌发病与死亡率的差异分析

Variations in incidence and mortality rates of endometrial cancer at the global, regional, and national levels, 1990-2019.
PubMed 文献 · Gynecol Oncol · 2021-02-05

该研究基于全球疾病负担数据库,分析1990-2019年子宫内膜癌年龄标化发病率和死亡率的变化趋势。全球发病率每年显著上升0.69%(95%CI 0.57-0.81%),160个国家/地区呈上升趋势;全球死亡率每年显著下降0.85%(95%CI -0.93至-0.76%),但91个国家/地区死亡率显著上升,莱索托增幅最高(EAPC=3.27)。

要点

  • 全球子宫内膜癌发病率普遍上升,意大利增幅最显著(EAPC=4.81)
  • 全球死亡率总体下降,但91个国家/地区死亡率上升,莱索托增幅最高
  • 发展中国家死亡率与发病率比值高于发达国家

核心结论

  • 全球子宫内膜癌发病率普遍增加,死亡率在全球层面下降但在许多国家上升,需加强疾病负担缓解措施。

研究设计与样本

  • 基于全球疾病负担数据库的流行病学分析,使用估计平均年度百分比变化(EAPC)量化1990-2019年年龄标化发病率和死亡率趋势。

主要发现

  • 全球子宫内膜癌年龄标化发病率每年显著增加0.69%(95%CI 0.57-0.81%),160个国家/地区呈上升趋势。
  • 意大利发病率增幅最显著(EAPC=4.81,95%CI 4.10-5.53),其次为沙特阿拉伯和新加坡。
  • 全球年龄标化死亡率每年显著下降0.85%(95%CI -0.93至-0.76%),但91个国家/地区死亡率显著上升。
  • 莱索托死亡率增幅最高(EAPC=3.27,95%CI 2.81-3.74)。
  • 发展中国家死亡率与发病率比值高于发达国家,该比值在国家层面呈下降趋势。

临床怎么用

  • 提示临床医生关注子宫内膜癌发病率持续上升的全球趋势,加强高危人群筛查与早期识别。
  • 在死亡率上升的国家/地区需强化诊疗可及性与规范化管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Endometrial cancer (EC) is a commonly diagnosed cancer in women. A comprehensive knowledge of its epidemiological features is essential for understanding the disease burden and guiding prevention strategies. METHODS: We retrieved the incidence and mortality data of EC from the Global Burden of Disease database. Estimated average percentage change (EAPC) was used to quantify the trends of the age-standardized incidence and mortality rates (ASIR and ASMR, respectively) of EC from 1990 to 2019. RESULTS: Globally, the ASIR of EC significantly increased by 0.69% (95% confidence interval [CI] 0.57-0.81%) per year between 1990 and 2019. This increasing trend was also observed in 160 countries or territories, regardless of the sociodemographic status. The most pronounced increase was found in Italy (EAPC = 4.81, 95% CI, 4.10-5.53), followed by Saudi Arabia and Singapore. Between 1990 and 2019, the ASMR of EC decreased significantly worldwide (EAPC = -0.85, 95% CI, -0.93 to -0.76) but increased significantly in 91 countries or territories, with the highest increase in Lesotho (EAPC = 3.27, 95% CI, 2.81-3.74). The ASMR-ASIR ratio of EC was higher in developing countries than in developed countries. This ratio showed a decreasing trend at the national level over the past three decades. CONCLUSIONS: EC incidence has ubiquitously increased worldwide. EC mortality has decreased at the global level but increased in many countries. More efforts are required to alleviate the disease burden of EC.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Gu B, Shang X, Yan M, et al. Variations in incidence and mortality rates of endometrial cancer at the global, regional, and national levels, 1990-2019. Gynecol Oncol. 2021. PMID: 33551200. doi:10.1016/j.ygyno.2021.01.036

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。